Phillips - Menopause Flashcards

1
Q

What is menopause?

A
  • 1 year without menses and FSH >30 (because estrogen goes down)
  • NOTE: women now spend about 40% of their lives in menopause, which begins around ag 45-55
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is perimenopause?

A
  • Age group near menopausal age, 45-55
  • With symptoms: menopausal transition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is post-menopause age group?

A
  • Postmenopause: beyond menopause, or age >55
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the biology of menopause?

A
  • End of reproductive life about age 43
  • Ovary continues to produce eggs sporadically, but they are abnormal
  • With ovulation, estrogen still being produced, but in lower amounts (no progesterone)
    1. With less amounts of estrogen being produced, FSH rises
    2. Menses becomes less frequent, lighter
  • Menopause defined as:
    1. No menses for a year
    2. FSH >30 (bc estrogen levels go down)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What things bring women to the OB to begin hormone therapy (bar chart)?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the symptoms of menopause?

A
  • Most common: hot flashes -> skin changes and vasodilation have been documented
  • May report waking up at night with sweats, then cooling effect -> may happen 5x/night, and disturb sleep
    1. If no treatment, will dissipate
  • Vaginal atrophy (can cause dyspareunia): late effect, but can tx w/estrogen, vaginal or systemic
  • Probably due to gonadotropin spikes as much as estrogen deficiency
  • May occur as peri-menopausal symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the FDA-approved indications for HRT?

A
  • Indicated for:
    1. Treatment of moderate-to-severe vasomotor symptoms associated with menopause -> 1o indication, and most common reason women start therapy
    2. Treatment of vulvar and vaginal atrophy: topical vaginal products should be considered
    3. Prevention of postmeno osteoporosis: FDA encourages consideration of non-estrogen meds when HT is prescribed solely for the prevention of postmenopausal osteoporosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the options for post-meno HRT?

A
  • Estrogen: can be taken alone only by women who have had a hysterectomy
    1. Estradiol pill, transdermal patch, or gel
    2. Conjugated estrogens: Premarin
  • Progestin added: for pts that have a uterus, to prevent endometrial hyperplasia and cancer:
    1. Medroxyprogesterone
    2. Micronized progesterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What symptoms are erroneously associated with menopause?

A
  • Depression
  • Lack of interest in sex
  • Going crazy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How should post-meno women with vaginal complaints only be treated?

A
  • Examples: dryness, dyspareunia
  • Preferred tx is low-dose, vaginal estrogen; FDA-approved use
  • NO need for progestins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What 3 medical illnesses are associated with menopause?

A
  • Osteoporosis
  • Heart disease
  • Cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Can estrogens be used to treat osteoporosis?

A
  • NO -> only used to prevent osteoporosis
    1. Individual risk factors
    2. Screening via BMD msmts starting at 65-y/o
    3. Should have another indication for HRT
    4. Affects osteoclast and osteoblast activity: even low-dose estrogen therapy can INC BMD
  • Tx is bisphosphonates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Who is at high-risk for osteoporosis?

A
  • High-risk groups:
    1. Caucasian/Asian
    2. Thin
    3. Smoker, alcohol Use
    4. Steroid Use
    5. Family History
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the effects of combo and estrogen HRT on fracture risk.

A
  • Significant reduction in hip, vertebral, and all fractures in Women’s Health Initiative study
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does estrogen affect CV risk?

A
  • Women protected from CVD until menopause (when compared to men)
  • Early loss of endogenous estrogen (via oophorectomy or premature ovarian failure, for example) is associated with CVD
  • Endogenous estrogen INC smooth muscle proliferation, lowers cholesterol, and improves vascular tone
  • Remember: also associated with VTE, PE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the natural history of CVD in most women?

A
  • 35-y/o: fatty streaks + minimal atherosclerotic plaques
  • 45-55: active progression of lesions (menopausal transition)
    1. 5-8 yrs post-meo: INC in plaques and intima-media thickening
  • > 65: complications start to develop, and women’s rate is equal to men’s
  • NOTE: statins and ASA may not have the same benefit in women that they do in men
17
Q

What did the WHI study conclude about HRT and CVD risk? How might the study design have influenced this result?

A
  • RCT that concluded: INC risk of CHD in HRT users versus those on placebo
  • However, women recruited were 50-79-y/o, and average age was 64-y/o -> likely already had CHD if they were over age 65
  • Only 10% were between 50 and 54, and 20% were b/t 54 and 59, or near menopausal onset
  • Theory that HRT has (+) effects when initiated peri-menopausally, but (-) effects when started post-menopausally
18
Q

How does menopausal status affect the CV effects of HRT?

A
  • Peri-menopausal use: positive effects on vascular remodeling -> DEC intimal thickening, and DEC incidence of plaques
  • Post-menopausal use: in women >65, plaques already formed, and the thrombogenic effects of estrogen clot off the artery
    1. AE’s in first year of use: MI’s in year 1 -> may have already had heart disease
  • STRATIFICATION by YEARS AFTER MENO: # of events INC with years since menopause
    1. <10: 0.76 HR; >10: 1.10 HR; >20: 1.66 HR
19
Q

Ms. R comes to you as a 40 y/o who recently had a TAH-BSO (removal of ovaries and uterus) for adhesions and pain. Because of her family hx of CHD, her surgeon would not put her on ET. She is having night sweats and is “miserable.”

Your thoughts?

A
  • This woman can definitely take hormones (“needs to be on them”)
  • Premature ovarian failure, or oopherectomy pre-menopausally associated with CHD
  • No personal history of CHD; statins are not a contraindication for ET
  • Do lipid profile and TREAT -> ESTROGEN
  • Maybe use non-oral formula (transdermal), but E only because she has had a hysterectomy
    1. Vaginal estrogen not absorbed systemically, so progesterone not needed
  • If she is 40, and needs hormone support, she could be on estrogen for 15 years because pre-menopausal (danger is in post-menopausal women)
20
Q

Is ET recommended as a therapy for coronary protection?

A
  • NO, but if woman comes in with premature ovarian failure -> give her estrogen if she wants to be on HRT
  • NOTE: Dr. Phillips also presented a study that said depriving estrogen to women has cost lives due to the ability of ET to reduce mortality in women with a hysterectomy
21
Q

What did WHI say about ET/EPT and risk of thrombotic events and colon cancer?

A
  • INC risk of DVT
    1. 50-59: no INC risk of stroke for ET/EPT
    2. 60-69: INC risk of stroke for ET (HR: 1.62)
  • Estrogen DEC risk of colon cancer
22
Q

What is the consensus on ET and risk of breast cancer?

A
  • Complex issue
  • INC risk in breast cancer in 3-5 yrs of continuous EPT therapy, but it may be the progestin that adds the risk
  • Risk is small, and DEC after HT is stopped
  • NOTE: only recommendation out there about an absolute age is that women should come off of these at age 65 because most women have heart disease by that time
23
Q

So, how should you treat pts coming in with complaints of menopausal symptoms?

A
  • Individual decision in terms of QOL and health priorities
  • Pt w/family hx of breast cancer (or a smoker) may make different decision than healthy woman w/bad hot flashes and no history -> INDIVIDUALIZATION IS KEY
    1. Options should be given depending on personal risk factors or health priorities
  • Take symptoms seriously and talk about treatment options -> treat women who want HT, but review risks, benefits, and alternatives
24
Q

22-y/o smoker comes in and wants OC estrogen. Can she take it?

A
  • Yes!
  • If you are 35 and older, you can’t be on estrogen; if she is 22, then she can
  • This will NOT increase her risk of heart attack and stroke more than just smoking
  • Do NOT put older, heavy smoker on estrogen -> look for alternatives, like SSRIs to relieve menopausal symptoms